The new KCE health economics guidelines 2025: how to deal with uncertainties
Have already registered
| Last name | First name | Organization |
|---|---|---|
| Abdallah | Khadidja | - |
| Block | Sebastien | Alexion Pharmaceuticals |
| Braspenning | Tinne | ISMS |
| Coppenrath | Marilyn | - |
| Coppens | Katrien | KS Pharma |
| Darquennes | Eline | MSD Europe Belgium SRL |
| De Cock | Roosmarijn | Axes Health BV |
| De Ruyck | Mimi | BAYER sa-nv |
| De Smet | Pascale | Insmed Netherlands BV |
| Dhaene | Barbara | LIVV - Two Point Zero Consultancy BV |
| Ghasemi | Nilofar | - |
| Hendrickx | Els | What ELS matters c.v. |
| Mergan | Stephanie | HEBIAS bv |
| Minnaert | An-Katrien | Axes Health BV |
| Theys | Kirstof | Axtalis BV |
| Tsakeu | Elyonore | ABBVIE |
| van Dijck | Patricia | Pharma.be |
| Van Geyt | Katrien | Axes Health BV |
| Vandendriessche | Frank | Ficaja Farma |
| Vanderdonck | Frank | Axtalis BV |
| Willaert | Marjan | pharma.be |